Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma.
暂无分享,去创建一个
Su-Jin Shin | Y. Min | H. Cha | Hawk Kim | J. Jung | K. Seo | Y. Jegal | J. Ahn | J. Baek | W. Kwon | Y. Noh | A. K. Jeong | C. Park | Jeong Won Kim | Jae‐Hoo Park | J. Shin